16 completed, 5 unknown, 1 enrolling by invitation, 1 not yet recruiting. 25 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 25 | Completed 16, Unknown 5, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1 |
Follow Diabetes Type 2: new trials by email Literature Review of Diabetes Type 2 trials Research Report on Diabetes Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With Diabetes Diabetes Oral Health Program, Stannous Fluoride Dentifrice, Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash - Diabetes Type 2, Periodontal Disease | Phase 4 | Enrolling by invitation | Colgate Palmolive | 10000 | 2026-05-26 | 2026-09-03 |
| The Effect of Empagliflozin and Metformin on Oxidative Capacity and Microvascular Reactivity of Skeletal Muscle in Patients With Type 2 Diabetes Mellitus Empagliflozin (Jardiance®), Metformin, Synjardy® 12.5mg/1000mg film-coated tablets - Diabetes Type 2 | Phase 4 | Recruiting | University Medical Centre Ljubljana | 54 | 2026-04-16 | 2026-08-18 |
| Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM Henagliflozin Proline Tablets treatment, Metformin XR treatment - Diabetes Type 2 | Phase 4 | Not yet recruiting | Bin Lu | 116 | 2025-12-30 | 2026-01-07 |
| Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes Metformin, Lifestyle - Diabetes Type 2, Osteoporosis | Phase 4 | Unknown | King Saud University | 111 | 2024-08-01 | 2024-06-03 |
| SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF Dapagliflozin tablet, Hypertonic Saline Solution, 1 Ml, Furosemide Injection - Heart Failure Acute, Diabetes Type 2 | Phase 4 | Unknown | University of Palermo | 544 | 2024-06-01 | 2024-06-06 |
| Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes EPAVasc, Corn Oil - Diabetes Type 2, Hypertriglyceridemia | Phase 4 | Unknown | University of Ioannina | 450 | 2023-12-01 | 2023-11-15 |
| Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus Semaglutide - Psoriasis Vulgaris, Diabetes Type 2 | Phase 4 | Completed | University of Banja Luka | 30 | 2023-05-03 | 2024-07-01 |
| Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety Dapagliflozin 10mg Tab, Lobeglitazone 0.5 mg, Dapagliflozin + Lobeglitazone - Diabetes Type 2 | Phase 4 | Unknown | Seoul National University Bundang Hospital | 99 | 2022-01-01 | 2023-08-14 |
| Baseline Oral Health Study: UnCoVer the Connections to General Health Subgingival chlorhexidine irrigation, Dental Supplies, Periodonal Treatment - Cardiovascular Diseases, Diabetes Type 2 | Phase 4 | Completed | University of North Carolina, Chapel Hill | 786 | 2021-09-28 | 2026-02-12 |
| Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults Biological samples - Kidney Transplant, Myeloma | Phase 4 | Completed | Centre Hospitalier Régional d'Orléans | 196 | 2021-03-26 | 2025-12-23 |
| Follow-up of NAFLD Patients With MRI-PDFF Empagliflozin 25 MG, Ursodeoxycholic acid, Pentoxifylline 400 MG - Diabetes Type 2, NAFLD | Phase 4 | Completed | Asmaa Abdelfattah Elsayed | 80 | 2020-12-01 | 2022-12-20 |
| High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy Vitamin D - Diabetes Type 2, Diabetic Neuropathies | Phase 4 | Completed | Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health | 68 | 2018-01-10 | 2020-05-06 |
| MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis Prolia, 60 Mg/mL Subcutaneous Solution, Teriparatide - Postmenopausal Osteoporosis, Diabetes Type 2 | Phase 4 | Completed | Medical University of Vienna | 26 | 2017-03-01 | 2023-01-26 |
| Mineralocorticoid Receptor Antagonists in Type 2 Diabetes Eplerenone, Placebo - Diabetes Type 2 | Phase 4 | Completed | Herlev Hospital | 140 | 2015-11-01 | 2018-06-01 |
| Effects of Pomegranate Juice on Oxidative Stress in Patients With type2 Diabetes pomegranate juice, lifestyle modification - Diabetes Type 2 | Phase 4 | Completed | National Nutrition and Food Technology Institute | 60 | 2014-11-01 | 2015-09-24 |
| Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy Ramipril, Clopidogrel - Diabetes Type 2, Diabetic Nephropathy | Phase 4 | Unknown | AHEPA University Hospital | 60 | 2012-07-01 | 2012-12-06 |
| Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan Insulin treatment during Ramadan, Standard of care - Diabetes Type 2, Treatment During Ramadan | Phase 4 | Completed | Meir Medical Center | 245 | 2011-09-01 | 2013-04-12 |
| Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients BIAsp 30, NPH/Reg - Diabetes Type 2 | Phase 4 | Completed | Tehran University of Medical Sciences | 160 | 2011-07-01 | 2013-06-28 |
| Evaluation of Block Duration in Type 2 Diabetes Patients ropivacaine - Diabetes Type 2 | Phase 4 | Completed | Pierre and Marie Curie University | 70 | 2011-07-01 | 2012-12-24 |
| Type 2 Diabetes and Ambulatory Surgery Patients Metformin continue, Metformin discontinue - Diabetes Type 2 | Phase 4 | Completed | University of Texas Southwestern Medical Center | 160 | 2010-03-22 | 2017-06-12 |
Showing 20 of 25. Sign in to see all of them.
Diabetes Mellitus, Type 2 (25) · Diabetes Mellitus (5) · Acquired Immunodeficiency Syndrome (1) · Bites and Stings (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Diabetic Nephropathies (1) · Diabetic Neuropathies (1) · Fasting (1) · Hematologic Neoplasms (1) · Hypergammaglobulinemia (1) · Hypernatremia (1) · Hypertension (1) · Hypertriglyceridemia (1) · Inflammation (1)
Endocrine System Diseases (25) · Glucose Metabolism Disorders (25) · Metabolic Diseases (25) · Nutritional and Metabolic Diseases (25) · Diabetes Mellitus (20) · Cardiovascular Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Bone Diseases (2) · Bone Diseases, Metabolic (2) · Diabetes Complications (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Signs and Symptoms (2) · Urogenital Diseases (2) · Vascular Diseases (2)
Metformin (3) · Insulin Detemir (2) · dapagliflozin (2) · empagliflozin (2) · Cetylpyridinium (1) · Clopidogrel (1) · Continuous Glucose Monitoring (1) · Corn Oil (1) · Denosumab (1) · Eplerenone (1) · Exenatide (1) · Furosemide (1) · Hydrochlorothiazide (1) · Insulin Glargine (1) · Mouthwashes (1)
AHEPA University Hospital (1) · Asmaa Abdelfattah Elsayed (1) · Bin Lu (1) · Centre Hospitalier Régional d'Orléans (1) · Colgate Palmolive (1) · Copenhagen University Hospital, Rigshospitalet (1) · Corewell Health East (1) · East Tennessee State University (1) · Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health (1) · Herlev Hospital (1) · King Saud University (1) · Medical University of Vienna (1) · Meir Medical Center (1) · National Nutrition and Food Technology Institute (1) · Novo Nordisk A/S (1)
United States (5) · Denmark (2) · France (2) · Greece (2) · Iran (2) · Austria (1) · Bosnia and Herzegovina (1) · Egypt (1) · Israel (1) · Russia (1) · Slovenia (1) · South Korea (1) · Sweden (1)
Alireza Esteghamati, M.D. (1) · Asmaa A Elsayed, PhD (1) · Charles A Stuart, MD (1) · Fotios S Iliadis, Lecturer of Internal Medicine (1) · Giuseppe Miceli, PhD (1) · Jelena Petkovic-Dabic (1) · Margareta Olsson-Birgersson (1) · Naim Shehadeh, MD (1) · Nassir Mo Al-dagari, PhD (1) · Pamela A Marcovitz, MD (1) · Philippe Cuvillon, PhD (1) · Robert A Vigersky, MD (1) · Saroja Voruganti, PhD (1) · Tatiana Karonova, PhD (1)
PMID 15963399, PMID 17251278, PMID 20607462, PMID 21440872, PMID 21885793, PMID 22002075, PMID 22980301, PMID 23348203, PMID 26234442, PMID 26240596, PMID 29933267, PMID 30044293, PMID 32139695, PMID 32709292, PMID 32970396, PMID 33068776, PMID 34447992, PMID 34463640, PMID 35224730, PMID 35241246, PMID 36607775
2015 (1)